Rimegepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine

Lipton, RB; Croop, R; Stock, EG; Stock, DA; Morris, BA; Frost, M; Dubowchik, GM; Conway, CM; Coric, V; Goadsby, PJ

Lipton, RB (reprint author), Montefiore Med Ctr, Albert Einstein Coll Med, Saul R Korey Dept Neurol, 1165 Morris Pk Ave, Bronx, NY 10461 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 381 (2): 142

Abstract

Background Calcitonin gene-related peptide receptor has been implicated in the pathogenesis of migraine. Rimegepant is an orally administered, small-m......

Full Text Link